Sign Up Today and Learn More About Commure Stock
Invest in or calculate the value of your shares in Commure or other pre-IPO companies through EquityZen's platform.
Commure Stock
FHIR-Compliant Development Platform for Health Systems
About Commure Stock
Founded
2017
Headquarters
San Francisco, CA, US
Total Funding
699M
Industries
Software, Professional Services, Health Care
Commure aims to provide an FHIR-compliant development platform for health systems, vendors, and startups to build healthcare applications and software. The platform is built with an AAA security framework, an event service bus, an API gateway, a flexible data store, terminology services, and healthcare-specific UI components.
Commure was founded in 2017 by Tim Ellis and Jordan Noone. Notable investors include Human Capital, Quiet Capital, General Catalyst, and Greenoaks Capital.
Commure Press Mentions
Stay in the know about the latest news on Commure
Augmedix acquired by Commure for $139M
healthcareitnews • Aug 03, 2024
General Catalyst-backed Commure to buy Augmedix in $139M deal
modernhealthcare • Aug 03, 2024
Augmedix Agrees to $139 Million Acquisition by Commure
marketwatch • Aug 03, 2024
Commure signs agreement to acquire Augmedix in $139m deal
finance • Aug 03, 2024
Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up
fiercehealthcare • Jul 24, 2024
Investors in Commure
Discover investors in Commure stock and explore their portfolio companies
Commure Management
Leadership team at Commure
Chief Executive Officer
Ashwini Zenooz
Chief Product and Engineering Officer
Abhijit Mitra
Join now and verify your accreditation status to gain access to:
- Commure current valuation
- Commure stock price
- Available deals in Commure and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Commure stock?
Accredited investors can buy pre-IPO stock in companies like Commure through EquityZen funds. These investments are made available by existing Commure shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Commure stock?
Shareholders can sell their Commure stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
